open access

Vol 68, No 3 (2009)
ORIGINAL ARTICLES
Published online: 2009-05-13
Submitted: 2012-02-06
Get Citation

Simvastatin attenuates intestinal ischaemia/reperfusion-induced injury in rat

B. Hajipour, M.H. Somi, F. Saberifar, M.R. Hemmati, N.A. Asl, A. Moein, A.M. Vatankhah, A.R. Nourazar, M.R. Nasirizade
Folia Morphol 2009;68(3):156-162.

open access

Vol 68, No 3 (2009)
ORIGINAL ARTICLES
Published online: 2009-05-13
Submitted: 2012-02-06

Abstract

Ischaemia/reperfusion (I/R) injury is commonly seen in the field of intestine surgical interventions, shock, trauma, and many other clinical conditions. Simvastatin is known to have antioxidant and anti-inflammatory properties. This study investigated the effect of simvastatin administration in a warm intestinal I/R model on TNF-α, antioxidant enzymes and intestinal tissue morphology.
Thirty-six male wistar rats underwent laparotomy under general anaesthesia. Simvastatin was administered from four days before ischaemia induction. The rats were divided in to three groups (n = 12): the sham goup, the I/R group, and the I/R + simvastatin group. Intestinal ischaemia was induced by superior mesenteric artery ligation with microvascular clamps for 60 minutes, and after ischaemia, blood perfusion was released into the tissue and a reperfusion phase was started, which lasted for 3 hours. After 3 hours, the animals were sacrificed and serum and tissue obtained for biochemical and histological study. In the simvastatin treated group, intestinal tissue injury, TNF-α level, and tissue malondealdehyde levels were significantly lower than in the I/R group (p < 0.05). Glutathion peroxidase and superoxide dismutase levels were significantly higher in the simvastatin treated group than in the I/R group (p < 0.05).
Simvastatin pretreatment reduced intestinal I/R injury and was associated with down- -regulation of serum TNF-α and tissue malondealdehyde level, and simvastatin administration maintained cellular antioxidant enzyme contents compared to the I/R group after 3 hours reperfusion time.

Abstract

Ischaemia/reperfusion (I/R) injury is commonly seen in the field of intestine surgical interventions, shock, trauma, and many other clinical conditions. Simvastatin is known to have antioxidant and anti-inflammatory properties. This study investigated the effect of simvastatin administration in a warm intestinal I/R model on TNF-α, antioxidant enzymes and intestinal tissue morphology.
Thirty-six male wistar rats underwent laparotomy under general anaesthesia. Simvastatin was administered from four days before ischaemia induction. The rats were divided in to three groups (n = 12): the sham goup, the I/R group, and the I/R + simvastatin group. Intestinal ischaemia was induced by superior mesenteric artery ligation with microvascular clamps for 60 minutes, and after ischaemia, blood perfusion was released into the tissue and a reperfusion phase was started, which lasted for 3 hours. After 3 hours, the animals were sacrificed and serum and tissue obtained for biochemical and histological study. In the simvastatin treated group, intestinal tissue injury, TNF-α level, and tissue malondealdehyde levels were significantly lower than in the I/R group (p < 0.05). Glutathion peroxidase and superoxide dismutase levels were significantly higher in the simvastatin treated group than in the I/R group (p < 0.05).
Simvastatin pretreatment reduced intestinal I/R injury and was associated with down- -regulation of serum TNF-α and tissue malondealdehyde level, and simvastatin administration maintained cellular antioxidant enzyme contents compared to the I/R group after 3 hours reperfusion time.
Get Citation

Keywords

simvastatin-Intestine; ischaemia/reperfusion; injury

About this article
Title

Simvastatin attenuates intestinal ischaemia/reperfusion-induced injury in rat

Journal

Folia Morphologica

Issue

Vol 68, No 3 (2009)

Pages

156-162

Published online

2009-05-13

Bibliographic record

Folia Morphol 2009;68(3):156-162.

Keywords

simvastatin-Intestine
ischaemia/reperfusion
injury

Authors

B. Hajipour
M.H. Somi
F. Saberifar
M.R. Hemmati
N.A. Asl
A. Moein
A.M. Vatankhah
A.R. Nourazar
M.R. Nasirizade

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By  "Via Medica sp. z o.o." sp.k., Świętokrzyska 73, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl